stockportfolio.pro
Eli Lilly and Company Revenue 2007–2025
Eli Lilly and Company (LLY) annual revenue by fiscal year, computed from SEC filings. Compound growth +7.2%/yr over 18 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $65.18B | +44.7% |
| FY 2024 | $45.04B | +32.0% |
| FY 2023 | $34.12B | +19.6% |
| FY 2022 | $28.54B | +0.8% |
| FY 2021 | $28.32B | +15.4% |
| FY 2020 | $24.54B | +9.9% |
| FY 2019 | $22.32B | +3.8% |
| FY 2018 | $21.49B | +7.6% |
| FY 2017 | $19.97B | -5.9% |
| FY 2016 | $21.22B | +6.3% |
| FY 2015 | $19.96B | +1.7% |
| FY 2014 | $19.62B | -15.1% |
| FY 2013 | $23.11B | +2.3% |
| FY 2012 | $22.60B | -6.9% |
| FY 2011 | $24.29B | +5.2% |
| FY 2010 | $23.08B | +5.7% |
| FY 2009 | $21.84B | +7.2% |
| FY 2008 | $20.37B | +9.3% |
| FY 2007 | $18.63B | — |
Source: Eli Lilly and Company SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's revenue?
Eli Lilly and Company (LLY) reported revenue of $65.18B for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's revenue changed over time?
Between fiscal 2007 and 2025, LLY's revenue grew at roughly 7.2% per year (compound annual rate), from $18.63B to $65.18B.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.